Abstract
GEN EdgeVol. 5, No. 1 TopicsASGCT News: Kelonia Lentiviral Particles May Solve In Vivo Delivery Hurdles for CAR T CellsKelonia reports that its in vivo Gene Placement System (iGPS) particles efficiently and specifically deliver CAR molecules to T cells, resulting in long-term tumor clearance without toxicity or chemotherapy in mice and non-human primatesJonathan D GrinsteinJonathan D GrinsteinSearch for more papers by this authorPublished Online:17 May 2023https://doi.org/10.1089/genedge.5.1.73AboutSectionsView articleView Full TextPDF/EPUB Permissions & CitationsPermissionsDownload CitationsTrack CitationsAdd to favorites Back To Publication ShareShare onFacebookTwitterLinked InRedditEmail View articleFiguresReferencesRelatedDetails Volume 5Issue 1Jan 2023 Information© 2023 by GEN PublishingTo cite this article:Jonathan D Grinstein.ASGCT News: Kelonia Lentiviral Particles May Solve In Vivo Delivery Hurdles for CAR T Cells.GEN Edge.Jan 2023.378-381.http://doi.org/10.1089/genedge.5.1.73Published in Volume: 5 Issue 1: May 17, 2023PDF download
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
